Literature DB >> 19215417

Both pertussis toxin-sensitive and insensitive g-proteins link melatonin receptor to inhibition of adenylate cyclase in the ovine pars tuberalis.

P J Morgan1, G Davidson, W Lawson, P Barrett.   

Abstract

Bordetella pertussis toxin (islet activating protein, IAP) has been used to investigate the G-proteins involved in mediating the action of the melatonin receptor. Melatonin inhibits iorskolin-stimulated cyclic AMP production in ovine pars tuberalis (PT) cells. In cells treated with IAP for 16 h this response is attenuated in a dose-dependent manner, but not abolished. IAP catalyses the incorporation of [(32) P-ADP]ribose into a 41 kd protein present in PT membranes, but this labelling can be reduced if PT cells are preincubated with IAP for 16 h. Treatment of crude membrane preparations with IAP (20 /ig/ml) suppresses the binding of 2-[(125) l]iodomelatonin by 20%, whereas 1 mM GTP alone reduces binding by 40%, and in combination with IAP its effect is additive (60% inhibition). Therefore, these results indicate that the melatonin receptor acts via two G-proteins, one pertussis toxin-sensitive and the other pertussis toxin-insensitive.

Entities:  

Year:  1990        PMID: 19215417     DOI: 10.1111/j.1365-2826.1990.tb00639.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  3 in total

1.  Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors.

Authors:  C Browning; I Beresford; N Fraser; H Giles
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  The end of a myth: cloning and characterization of the ovine melatonin MT(2) receptor.

Authors:  F Cogé; S P Guenin; I Fery; M Migaud; S Devavry; C Slugocki; C Legros; C Ouvry; W Cohen; N Renault; O Nosjean; B Malpaux; P Delagrange; J A Boutin
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

3.  Identification of Key Regions Mediating Human Melatonin Type 1 Receptor Functional Selectivity Revealed by Natural Variants.

Authors:  Alan Hegron; Eunna Huh; Xavier Deupi; Badr Sokrat; Wenwen Gao; Christian Le Gouill; Mickaël Canouil; Mathilde Boissel; Guillaume Charpentier; Ronan Roussel; Beverley Balkau; Philippe Froguel; Bianca Plouffe; Amélie Bonnefond; Olivier Lichtarge; Ralf Jockers; Michel Bouvier
Journal:  ACS Pharmacol Transl Sci       Date:  2021-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.